A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer
Clinical trial NCT00058552 · COMPLETED
Trial details
- NCT number
- NCT00058552
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2004-07-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.